# Sensitivity of Pharmacokinetics to Differences in Particle Size Distribution of Suspension-based Nasal Sprays

> **NCT02588326** · PHASE1 · COMPLETED · sponsor: **University of Florida** · enrollment: 80 (actual)

## Conditions studied

- Hypersensitivity

## Interventions

- **DRUG:** Mometasone furoate drug formulation (MFF) 1
- **DRUG:** Mometasone furoate drug formulation (MFF) 2

## Key facts

- **NCT ID:** NCT02588326
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-21
- **Primary completion:** 2020-07-08
- **Final completion:** 2021-04-16
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2021-11-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02588326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02588326, "Sensitivity of Pharmacokinetics to Differences in Particle Size Distribution of Suspension-based Nasal Sprays". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02588326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*